| Mr Syed Jafar Raza, MD | |
|
15962 Quantico Rd, Apple Valley, CA 92307-1302 | |
| (760) 242-7560 | |
| (760) 242-7563 |
| Full Name | Mr Syed Jafar Raza |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 35 Years |
| Location | 15962 Quantico Rd, Apple Valley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275609588 | NPI | - | NPPES |
| 00A59520 | Medicaid | CA |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center | Apple valley, CA | Hospital |
| Desert Valley Hospital | Victorville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Syed J Raza Md Inc | 3274508569 | 2 |
News Archive
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
OncoGenex Pharmaceuticals, Inc. announced today initial results from the Phase 2 Rainier study evaluating apatorsen in combination with ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) and gemcitabine compared to ABRAXANE and gemcitabine alone in patients with untreated metastatic pancreatic cancer.
A new study, released as a preprint on the medRxiv* server, shows how the successful rollout of effective COVID-19 vaccines in this metropolis led to the dramatic reduction in the number of cases with moderate to severe coronavirus disease 2019 (COVID-19) and curbed COVID-19-related mortality.
Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
› Verified 1 days ago
| Entity Name | Syed J Raza Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750570248 PECOS PAC ID: 3274508569 Enrollment ID: O20040831000301 |
News Archive
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
OncoGenex Pharmaceuticals, Inc. announced today initial results from the Phase 2 Rainier study evaluating apatorsen in combination with ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) and gemcitabine compared to ABRAXANE and gemcitabine alone in patients with untreated metastatic pancreatic cancer.
A new study, released as a preprint on the medRxiv* server, shows how the successful rollout of effective COVID-19 vaccines in this metropolis led to the dramatic reduction in the number of cases with moderate to severe coronavirus disease 2019 (COVID-19) and curbed COVID-19-related mortality.
Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Syed Jafar Raza, MD Po Box 2680, Victorville, CA 92393-2680 Ph: (760) 242-7560 | Mr Syed Jafar Raza, MD 15962 Quantico Rd, Apple Valley, CA 92307-1302 Ph: (760) 242-7560 |
News Archive
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
OncoGenex Pharmaceuticals, Inc. announced today initial results from the Phase 2 Rainier study evaluating apatorsen in combination with ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) and gemcitabine compared to ABRAXANE and gemcitabine alone in patients with untreated metastatic pancreatic cancer.
A new study, released as a preprint on the medRxiv* server, shows how the successful rollout of effective COVID-19 vaccines in this metropolis led to the dramatic reduction in the number of cases with moderate to severe coronavirus disease 2019 (COVID-19) and curbed COVID-19-related mortality.
Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
› Verified 1 days ago
Dr. Khoi N Nguyen, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 15982 Quantico Rd, Suite F, Apple Valley, CA 92307 Phone: 760-242-3768 Fax: 760-242-5601 | |
Dr. Neera Grover, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16018 Tuscola Rd, Apple Valley, CA 92307 Phone: 760-242-0375 | |
Radha Menon, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18056 Wika Rd Ste C, Apple Valley, CA 92307 Phone: 760-242-3040 Fax: 760-242-5495 | |
Dr. Robert Mathew Boldy, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 18077 Us Highway 18 Ste 100, Apple Valley, CA 92307 Phone: 760-946-8169 | |
Dr. Ramesh D Bambhania, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16003 Tuscola Rd, Suite H, Apple Valley, CA 92307 Phone: 760-699-1110 | |
Dr. Sunil Hasmukh Patel, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16003 Tuscola Rd., Suite H, Apple Valley, CA 92307 Phone: 760-810-0888 Fax: 760-810-7060 | |
Hisham Jihad Abukamleh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18144 Us Highway 18 Ste 140, Apple Valley, CA 92307 Phone: 760-515-4003 |